| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/08/2001 | EP1121124A1 Pharmaceutical combination of ibuprofen-lysine and domperidone for treating migraine |
| 08/08/2001 | EP1121123A2 Formulations of fexofenadine |
| 08/08/2001 | EP1121122A1 Treatment of depression |
| 08/08/2001 | EP1121121A2 Methods for inhibiting diabetic complications |
| 08/08/2001 | EP1121120A1 Use of ophthalmic composition comprising vitamin a and vitamin e |
| 08/08/2001 | EP1121119A1 A new composition |
| 08/08/2001 | EP1121118A1 Formamides as therapeutic agents |
| 08/08/2001 | EP1121117A2 Oxaliplatinum preparation packaging |
| 08/08/2001 | EP1121116A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 08/08/2001 | EP1121115A1 Pufa supplements |
| 08/08/2001 | EP1121114A1 Method for the treatment of mania and bipolar disorder |
| 08/08/2001 | EP1121113A1 Methods for regulating bone formation |
| 08/08/2001 | EP1121112A2 Storable active substance concentrate with formoterol |
| 08/08/2001 | EP1121111A2 Compounds for the treatment of weight loss |
| 08/08/2001 | EP1121110A1 Use of metformin to counteract weight gain associated with valproate and other psychotropic medications |
| 08/08/2001 | EP1121109A2 Opioid analgesic |
| 08/08/2001 | EP1121108A2 Novel therapeutic use of compounds with beta-3-agonist activity |
| 08/08/2001 | EP1121107A2 Sertraline oral concentrate |
| 08/08/2001 | EP1121106A1 Treatment of dyspepsia |
| 08/08/2001 | EP1121105A1 Propofol-based anesthetic and method of making same |
| 08/08/2001 | EP1121104A2 New sustained release oral formulations |
| 08/08/2001 | EP1121103A2 Orally disintegrable tablets |
| 08/08/2001 | EP1121102A1 Liposome-entrapped topoisomerase inhibitors |
| 08/08/2001 | EP1121101A1 Aerosol ointment compositions and method of manufacture |
| 08/08/2001 | EP1121100A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 08/08/2001 | EP1121099A1 Pharmaceutical composition with gastric residence and controlled release |
| 08/08/2001 | EP1121098A2 Cream cleanser with high levels of emollients and glycerin |
| 08/08/2001 | EP1121096A1 Uv protection compositions |
| 08/08/2001 | EP1121095A1 Uv protection compositions |
| 08/08/2001 | EP1121088A1 Use of nanoscale sterols and sterol esters |
| 08/08/2001 | EP1054595A4 Methods and compounds for the genetic treatment of hyperlipidemia |
| 08/08/2001 | EP1044005A4 1,2,4-benzotriazine oxides formulations |
| 08/08/2001 | EP1024792A4 Topical antifungal composition |
| 08/08/2001 | EP1019037B1 Medicament containing delta-aminolevulinic acid |
| 08/08/2001 | EP1011692A4 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY |
| 08/08/2001 | EP0965342B1 Preparation for percutaneous administration containing 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazole |
| 08/08/2001 | EP0960118A4 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon |
| 08/08/2001 | EP0889051B1 Triterpene derivatives and remedies for liver diseases |
| 08/08/2001 | EP0869956B1 Pharmaceutical compositions |
| 08/08/2001 | EP0839159B1 Polysaccharide gel composition |
| 08/08/2001 | EP0824357B1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 08/08/2001 | EP0822816B1 Dermatological preparation for treating actinic keratoses |
| 08/08/2001 | EP0815112B1 Process for isolating galanthamine |
| 08/08/2001 | EP0798298B1 Thiazolidinone or oxazolidinone derivatives to treat angina pectoris or compositions containing the same as active ingredient |
| 08/08/2001 | EP0766682B1 Protein kinase c inhibitors |
| 08/08/2001 | EP0740679B1 Crosslinked polymeric ammonium salts |
| 08/08/2001 | EP0625155B1 Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors |
| 08/08/2001 | CN1307636A Endometriosis-associated gene |
| 08/08/2001 | CN1307628A Stable carbanilide composition |
| 08/08/2001 | CN1307584A Macrolide LHRH antagonists |
| 08/08/2001 | CN1307583A Method for preparing aloin by extraction |
| 08/08/2001 | CN1307580A Syntheses of variety of lamellarin compounds and analogues |
| 08/08/2001 | CN1307579A Substituted triazolo-pyridazing derivative, pharmaceutical composition made therefrom |
| 08/08/2001 | CN1307578A Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| 08/08/2001 | CN1307577A Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 08/08/2001 | CN1307576A Serotongergic agents |
| 08/08/2001 | CN1307575A New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same |
| 08/08/2001 | CN1307574A Indolyl derivatives as serotonergic agents |
| 08/08/2001 | CN1307573A Indolyl derivatives and serotonergic agents |
| 08/08/2001 | CN1307571A Guanidine derivatives |
| 08/08/2001 | CN1307569A New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralines and their use |
| 08/08/2001 | CN1307568A Crystalline efavirenz |
| 08/08/2001 | CN1307567A 1,5 benzodiazepine derivatives |
| 08/08/2001 | CN1307566A Pyrazoline derivatives, their prep. and application as medicaments |
| 08/08/2001 | CN1307565A Quinolones used as MRS inhibitor and bactericides |
| 08/08/2001 | CN1307564A Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 08/08/2001 | CN1307562A Antipsychotic indolyl derivatives |
| 08/08/2001 | CN1307561A Novel VLA-4 inhibitor: oMePUPA-V |
| 08/08/2001 | CN1307560A Amidino and guanidino beta-azetidinone tryptase inhibitors |
| 08/08/2001 | CN1307559A Substituted beta-diketones and their use |
| 08/08/2001 | CN1307487A Method of treating endotoxemia |
| 08/08/2001 | CN1307486A Pharmaceutical levothyroxine preparation |
| 08/08/2001 | CN1307479A Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression |
| 08/08/2001 | CN1307477A Method and composition for treatment of inflammatory conditions |
| 08/08/2001 | CN1307476A Sustained release oral preparations of fasudil hydrochloride |
| 08/08/2001 | CN1307475A Medicinal compositions |
| 08/08/2001 | CN1307474A Therapeutic agents |
| 08/08/2001 | CN1307473A Triterpene compositions and methods for use thereof |
| 08/08/2001 | CN1307472A Compositions comprising organic mono-or dinitrate for treating impotence |
| 08/08/2001 | CN1307471A Use of NMDA antagonists for treatment of irritable bowel syndrome |
| 08/08/2001 | CN1307470A Pharmaceutical formulations for aerosols with two or more active substances |
| 08/08/2001 | CN1306861A Polysaccharide with certain immunological activity and its preparation |
| 08/08/2001 | CN1306847A Ointment for treating prostatitis and its usage |
| 08/08/2001 | CN1306833A External-use extract for treating burns and scalds fast and its preparation |
| 08/08/2001 | CN1306824A Water soluble medical chitose preparation and its preparation |
| 08/08/2001 | CN1306823A Ointment for treating dermatosis and its preparation |
| 08/08/2001 | CN1306822A Medicament for treating dermatosis and its preparation |
| 08/08/2001 | CN1306821A Application and usage of Miconazole cream |
| 08/08/2001 | CN1306820A Phentolaminum capsule and its preparation |
| 08/08/2001 | CN1306819A Preparation of isation medicine for preventing and treating senile neuropathy |
| 08/08/2001 | CN1306818A Medicine for treating abacterial inflammation and its extraction method |
| 08/08/2001 | CN1069323C Gaseous polymerization method |
| 08/08/2001 | CN1069322C Antisense digonucleotide and use thereof |
| 08/08/2001 | CN1069321C New inhibitors of platelet aggregation |
| 08/08/2001 | CN1069319C Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 08/08/2001 | CN1069318C Cyclic gmp-specific phosphodiesterase inhibitors |
| 08/08/2001 | CN1069317C Novel indane-2-mercaptoacetamide disulfide derivs, useful as inhibitors of enkephaliinase |
| 08/08/2001 | CN1069316C Substituted 5-ring heterocycles, their preparation and use |
| 08/08/2001 | CN1069312C Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 08/08/2001 | CN1069309C N-(aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphtalene-2-carboxamide derivative, preparation and application thereof |